April 26, 17.25 PM IST || Pocket News Alert
~ First such therapy that will be made available for benefit of people with haemophilia A in India~
Chandigarh, 26 April 2016. Novo Nordisk, a leading player in haemophilia care, today launched NovoeightTM,(Antihemophilic Factor [Recombinant]) in India for use in the treatment and prevention of bleeding in people with haemophilia A (congenital
↧